1. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients
   Zhiqi Song et al, 2022, Signal Transduction and Targeted Therapy CrossRef
2. The relationship between anesthesia and melatonin: a review
   Rui Guo et al, 2023, Frontiers in Pharmacology CrossRef
3. Novel Coronavirus disease (COVID-19): physiology to pathophysiology and therapeutics including herbal medicines
   Shah Mohammad Abbas Waseem et al, 2023, Infectious Diseases and Herbal Medicine CrossRef
4. In vitro Modified Release Studies on Melatoninergic Fluorinated Phenylalkylamides: Circumventing their Lipophilicity for Oral Administration
   Marilena Vlachou et al, 2024, Current Pharmaceutical Design CrossRef
5. Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
   Adel S. Girgis et al, 2023, Molecules CrossRef
6. COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies
   Domenico Iacopetta et al, 2022, Viruses CrossRef
7. Comprehensive review of melatonin as a promising nutritional and nutraceutical supplement
   Waad W. Kamfar et al, 2024, Heliyon CrossRef
8. The role of melatonin as an adjuvant in the treatment of COVID-19: A systematic review
   Arezoo Faridzadeh et al, 2022, Heliyon CrossRef
9. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?
   Amarnath Sen, 2021, Medical Hypotheses CrossRef
10. “LONG COVID”—A hypothesis for understanding the biological basis and pharmacological treatment strategy
    Bevyn Jarrott et al, 2022, Pharmacology Research & Perspectives CrossRef
11. Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
    A. Satyanarayan Naidu et al, 2024, npj Science of Food CrossRef
12. SARS-CoV-2 Infection and the Neuroendocrine System
    Shruti Sasikumar et al, 2024, Neuroendocrinology CrossRef
13. SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role?
    Paul Zimmermann et al, 2023, Journal of Cardiovascular Development and Disease CrossRef
14. Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6‐Dihydroindolo[2,1‐a]isoquinolines and Related Systems
    Andrew Tsotinis et al, 2022, ChemMedChem CrossRef
15. MicroRNA-124-3p promotes apoptosis and autophagy of glioma cells by down-regulating CREBRF
    Huan Zeng et al, 2022, Neurological Research CrossRef
16. Modified Release of the Pineal Hormone Melatonin from Matrix Tablets Containing Poly(L-lactic Acid) and Its PLA-co-PEAd and PLA-co-PBAd Copolymers
    Marilena Vlachou et al, 2022, Polymers CrossRef
17. Peganutonin A, a novel melatonin analogue from the seeds of Peganum harmala
    Jian-Bo Liu et al, 2023, Phytochemistry Letters CrossRef
18. Potent Lipophilic Melatoninergic x-fluoro-y-methoxy Substituted Phenylalkylamides: Molecular Dynamics Calculations and in vitro Modified Release in Aqueous Media from Tablet Formulations
    Marilena Vlachou et al, 2023, Current Pharmaceutical Design CrossRef
19. Recent advances in management of COVID-19: A review
    Soraya Mouffak et al, 2021, Biomedicine & Pharmacotherapy CrossRef
20. Unlocking the health benefits of melatonin supplementation: A promising preventative and therapeutic strategy
    Firas S. Azzeh et al, 2024, Medicine CrossRef
21. Vitamin C and its therapeutic potential in the management of COVID19
    Neethu RS et al, 2022, Clinical Nutrition ESPEN CrossRef
22. Melatonin and other indoles show antiviral activities against swine coronaviruses in vitro at pharmacological concentrations
    Xiaofeng Zhai et al, 2021, Journal of Pineal Research CrossRef
23. The pineal gland
    Gerald Litwack, 2022, Hormones CrossRef
24. The NLRP3 inflammasome and gut dysbiosis as a putative link between HIV-1 infection and ischemic stroke
    Silvia Torices et al, 2023, Trends in Neurosciences CrossRef